BACKGROUND: Changes in the epidemiological characteristics of measles since 2007 appeared in the Jiangsu province. Although the reported coverage with two doses of measles vaccine was greater than 95% in most regions of the province, measles incidence remained high across the whole province. Cross-sectional serological surveys of measles antibodies in the Jiangsu province of China were conducted from 2008 to 2010 to assess and track population immunity. METHODS: Measles-specific IgG levels were measured in serum samples using ELISA. GMTs and seroprevalence with 95% CIs were calculated by region, gender, and age. ANOVA and χ(2) tests were used to test for statistically significant differences between groups for GMT levels and seroprevalence, respectively. RESULTS: Seroprevalence showed a significantly increasing trend annually (CMH χ(2) = 40.32, p<0.0001). Although the seroprevalence among children aged 2-15 years was consistently over 95%, vaccine-induced measles antibodies may wane over time. Measles seropositivity in the Jiangsu province was 91.7% (95% CI: 90.1-93.2%) in 2010. Among adults aged 15 to 29-year-olds, the seropositivity rate was 88.4% (95% CI: 82.7-92.8%). CONCLUSIONS: Vaccination strategies may need to be adjusted depending on the individual age and regions, particularly individuals between the ages of 8 months-14 years old and 20-29 years old. Additional SIAs are likely required to eliminate measles in China.
BACKGROUND: Changes in the epidemiological characteristics of measles since 2007 appeared in the Jiangsu province. Although the reported coverage with two doses of measles vaccine was greater than 95% in most regions of the province, measles incidence remained high across the whole province. Cross-sectional serological surveys of measles antibodies in the Jiangsu province of China were conducted from 2008 to 2010 to assess and track population immunity. METHODS:Measles-specific IgG levels were measured in serum samples using ELISA. GMTs and seroprevalence with 95% CIs were calculated by region, gender, and age. ANOVA and χ(2) tests were used to test for statistically significant differences between groups for GMT levels and seroprevalence, respectively. RESULTS: Seroprevalence showed a significantly increasing trend annually (CMH χ(2) = 40.32, p<0.0001). Although the seroprevalence among children aged 2-15 years was consistently over 95%, vaccine-induced measles antibodies may wane over time. Measles seropositivity in the Jiangsu province was 91.7% (95% CI: 90.1-93.2%) in 2010. Among adults aged 15 to 29-year-olds, the seropositivity rate was 88.4% (95% CI: 82.7-92.8%). CONCLUSIONS: Vaccination strategies may need to be adjusted depending on the individual age and regions, particularly individuals between the ages of 8 months-14 years old and 20-29 years old. Additional SIAs are likely required to eliminate measles in China.
Authors: N Andrews; R G Pebody; G Berbers; C Blondeau; P Crovari; I Davidkin; P Farrington; F Fievet-Groyne; G Gabutti; E Gerike; C Giordano; L Hesketh; T Marzec; P Morgan-Capner; K Osborne; A M Pleisner; M Raux; A Tischer; U Ruden; M Valle; E Miller Journal: Epidemiol Infect Date: 2000-08 Impact factor: 2.451
Authors: Angela Bechini; Sara Boccalini; Emilia Tiscione; Giovanna Pesavento; Francesco Mannelli; Marta Peruzzi; Stefano Rapi; Stefano Mercurio; Paolo Bonanni Journal: Eur J Public Health Date: 2010-09-29 Impact factor: 3.367
Authors: B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory Journal: Epidemiol Infect Date: 2014-11-06 Impact factor: 4.434
Authors: Daniel Olson; Molly M Lamb; Maria Renee Lopez; M Alejandra Paniagua-Avila; Alma Zacarias; Gabriela Samayoa-Reyes; Celia Cordon-Rosales; Edwin J Asturias Journal: Open Forum Infect Dis Date: 2017-03-17 Impact factor: 3.835
Authors: Xiaoqin Wang; Mei Ma; Zhaozhao Hui; Paul D Terry; Yue Zhang; Rui Su; Mingxu Wang; Wei Gu; Ling Li Journal: Int J Environ Res Public Health Date: 2017-06-06 Impact factor: 3.390